Fused ring compounds for inflammation and immune-related uses
US8779154B2 · kind B2 · utility
0Cited by
5References
29Claims
0Family size
Inventors
Key dates
| Filing date | Sep 25, 2007 |
| Grant date | Jul 15, 2014 |
| Priority date | — |
| Expiry date | Sep 25, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to certain fused ring compounds, or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.